KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hancock Whitney (HWC) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Hancock Whitney (HWC) over the last 11 years, with Sep 2025 value amounting to $514.6 million.

  • Hancock Whitney's Cash & Equivalents fell 9.70% to $514.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.6 million, marking a year-over-year decrease of 9.70%. This contributed to the annual value of $574.9 million for FY2024, which is 2.44% up from last year.
  • As of Q3 2025, Hancock Whitney's Cash & Equivalents stood at $514.6 million, which was up 0.41% from $512.5 million recorded in Q2 2025.
  • Over the past 5 years, Hancock Whitney's Cash & Equivalents peaked at $703.4 million during Q1 2022, and registered a low of $401.2 million during Q4 2021.
  • For the 3-year period, Hancock Whitney's Cash & Equivalents averaged around $532.5 million, with its median value being $541.4 million (2023).
  • In the last 5 years, Hancock Whitney's Cash & Equivalents surged by 40.69% in 2022 and then slumped by 30.30% in 2024.
  • Quarterly analysis of 5 years shows Hancock Whitney's Cash & Equivalents stood at $401.2 million in 2021, then soared by 40.69% to $564.5 million in 2022, then dropped by 0.58% to $561.2 million in 2023, then climbed by 2.44% to $574.9 million in 2024, then declined by 9.70% to $514.6 million in 2025.
  • Its Cash & Equivalents was $514.6 million in Q3 2025, compared to $512.5 million in Q2 2025 and $510.3 million in Q1 2025.